The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage.
about
Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizuresExperimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neuronsNeuroprotection against excitotoxic brain injury in mice after ovarian steroid depletionEnhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus.Ketamine controls prolonged status epilepticusPhenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus.Central cholinesterase inhibition enhances glutamatergic synaptic transmission.A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation.Acute cellular alterations in the hippocampus after status epilepticus.Variation in Galr1 expression determines susceptibility to exocitotoxin-induced cell death in mice.Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptorsSusceptibility to seizure-induced excitotoxic cell death is regulated by an epistatic interaction between Chr 18 (Sicd1) and Chr 15 (Sicd2) loci in mice.Congenic strains provide evidence that a mapped locus on chromosome 15 influences excitotoxic cell deathTime course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry.Methamphetamine-induced neuronal necrosis: the role of electrographic seizure discharges.Status epilepticus: the past and the future.Neuroprotection in epilepsy.Microarray-assisted fine mapping of quantitative trait loci on chromosome 15 for susceptibility to seizure-induced cell death in mice.Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication.Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia.Role of Neuronal Loss in the Pathogenesis of Recurrent Spontaneous Seizures.Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms.Memantine delayed N-methyl-D-aspartate -induced convulsions in neonatal rats.Caspase-3 is not activated in seizure-induced neuronal necrosis with internucleosomal DNA cleavage.[Acute alterations of neurotransmitters levels in striatum of young rat after pilocarpine-induced status epilepticus].Lithium-pilocarpine-induced status epilepticus produces necrotic neurons with internucleosomal DNA fragmentation in adult rats.Neuroprotective effect of ketamine administered after status epilepticus onset.
P2860
Q28372863-88E19884-FE73-419E-A45A-70982BC12645Q28378739-B25C19BC-DBF0-4FD1-AF2E-13942688085AQ28388388-49F90F56-2B39-4E6F-8742-9D84969BA560Q30252723-24775EF0-466C-4C5F-A51C-56A001210C88Q30306363-9294FF49-4229-466A-B05B-33211AAE6417Q30308667-FD5D0EEB-890F-4EC6-9ABD-C6B6655EFE94Q30432854-7130E35D-67D3-45CD-9188-0BA269007E6DQ30433508-6275D48A-CF12-4CC4-82FF-DC3FC45B621BQ30436689-11D3ED54-63A4-49B5-A8D1-6357F464F624Q33696608-FCF2A672-EE75-4812-B008-373CDE890D9FQ33718543-9C8B52BF-4991-45E3-9D02-3C7AB2C2AEA7Q33943268-4CDD4C5A-8D8C-46D2-BD7B-C93DAB990927Q34344249-A9274F67-B684-4BD7-A05C-8E1708633261Q34420451-0AB34E5C-08FF-4BAD-A9F4-AED373B0DE8AQ36571496-68EE3E5A-35DB-4BCC-8E42-8246EB13D78DQ36833995-0938BA85-3E64-49C2-926F-B8E0BE58BF68Q37105984-AA47337E-054F-499C-AD50-C0C60AF4E60CQ37106016-C9D96A6F-EB21-4B5A-A4C0-C9D1866B1811Q37444153-2A9D5F85-C47D-42D6-B30D-2E1AE239CBF6Q39327872-21A0E521-9463-438A-A90D-BBE84D33B194Q40444545-5F8B0A87-4E93-4FF2-9588-9113A1474821Q40467674-35E59CBB-02F4-4509-938E-BCCEE5BE7461Q41660762-5B05D758-6466-474F-A8D0-37F7AE0DBDF9Q43507386-52FBD010-DACF-43F9-8394-BF1DD50F17C1Q43994143-1F3B016B-1B77-4FEC-A741-50B9001855F4Q44163182-3F80C2BB-76BA-4886-AA68-B875249F4E2DQ44534521-4DCD8F64-E67F-451E-9CAA-3AB7212A38E5Q48228511-70C87638-D356-4785-812A-C60655B43532Q51611181-ECA3B334-7517-4254-98B0-A35284844E44
P2860
The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@ast
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@en
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@nl
type
label
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@ast
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@en
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@nl
prefLabel
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@ast
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@en
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@nl
P2093
P1433
P1476
The competitive NMDA receptor ...... ticus-induced neuronal damage.
@en
P2093
P304
P356
10.1016/0920-1211(94)90051-5
P577
1994-03-01T00:00:00Z